$MRAI
Marpai, Inc.

2022 Q3 Form 10-Q Financial Statement

#000141057822002513 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $4.938M $5.557M $6.219M
YoY Change 2.89% 57.34%
Cost Of Revenue $3.625M $8.698M $4.547M
YoY Change 8.44% 219.74%
Gross Profit $1.313M $3.077M $1.672M
YoY Change -9.85% 279.39%
Gross Profit Margin 26.58% 55.38% 26.89%
Selling, General & Admin $3.772M $4.537M $4.461M
YoY Change -1.23% 42.56% 297.28%
% of Gross Profit 287.33% 147.44% 266.82%
Research & Development $781.8K $1.309M $593.1K
YoY Change 37.43% 358.77% 124.65%
% of Gross Profit 59.55% 42.55% 35.47%
Depreciation & Amortization $82.07K $72.09K $825.4K
YoY Change 40.18% 24.49% 4446.65%
% of Gross Profit 6.25% 2.34% 49.37%
Operating Expenses $4.553M $5.846M $5.054M
YoY Change 3.78% 68.59% 264.42%
Operating Profit -$5.814M -$6.664M -$5.539M
YoY Change 22.78% 67.81% 294.17%
Interest Expense $2.908K $562.00 $3.945K
YoY Change -97.32% -99.39% -97.85%
% of Operating Profit
Other Income/Expense, Net $56.27K -$9.706K $49.00K
YoY Change 3.0% -120.34% 631.52%
Pretax Income -$5.780M -$6.665M -$5.490M
YoY Change 20.6% 65.71% 244.91%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.780M -$6.665M -$5.490M
YoY Change 20.6% 72.13% 244.91%
Net Earnings / Revenue -117.05% -119.95% -88.28%
Basic Earnings Per Share -$0.28 -$0.34 -$0.28
Diluted Earnings Per Share -$0.28 -$0.34 -$0.28
COMMON SHARES
Basic Shares Outstanding 20.68M 19.85M 19.63M
Diluted Shares Outstanding 20.35M 19.85M 19.63M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.748M $9.085M $14.11M
YoY Change 298.66% 288.37%
Cash & Equivalents $4.748M $9.085M $14.11M
Short-Term Investments
Other Short-Term Assets $5.333M $6.610M $8.571M
YoY Change -37.88% 7.56%
Inventory
Prepaid Expenses
Receivables $191.2K $26.48K $110.4K
Other Receivables $56.83K $27.29K $89.97K
Total Short-Term Assets $10.35M $15.75M $22.88M
YoY Change 1.77% 82.66%
LONG-TERM ASSETS
Property, Plant & Equipment $737.4K $761.6K $922.5K
YoY Change 2.34% -68.77%
Goodwill $2.383M $2.383M $2.383M
YoY Change 42.16%
Intangibles $4.930M $5.122M $5.288M
YoY Change -24.2%
Long-Term Investments
YoY Change
Other Assets $80.61K $80.61K $80.61K
YoY Change 54.19% 54.19%
Total Long-Term Assets $15.07M $15.85M $16.75M
YoY Change -11.97% -10.93%
TOTAL ASSETS
Total Short-Term Assets $10.35M $15.75M $22.88M
Total Long-Term Assets $15.07M $15.85M $16.75M
Total Assets $25.41M $31.60M $39.63M
YoY Change -6.85% 19.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $692.9K $490.1K $1.065M
YoY Change -73.86% -5.29%
Accrued Expenses $2.339M $2.321M $2.174M
YoY Change 20.99% -69.06%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.650M $9.535M $11.97M
YoY Change -41.27% 5.93%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $45.00K $45.00K $45.00K
YoY Change 0.0% -96.42%
Total Long-Term Liabilities $45.00K $45.00K $45.00K
YoY Change 0.0% -99.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.650M $9.535M $11.97M
Total Long-Term Liabilities $45.00K $45.00K $45.00K
Total Liabilities $11.42M $12.53M $15.17M
YoY Change -49.6% -27.44%
SHAREHOLDERS EQUITY
Retained Earnings -$39.46M -$33.68M -$27.02M
YoY Change 149.79%
Common Stock $2.094K $2.068K $2.030K
YoY Change 87.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.99M $19.07M $24.47M
YoY Change
Total Liabilities & Shareholders Equity $25.41M $31.60M $39.63M
YoY Change -6.85% 19.62%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$5.780M -$6.665M -$5.490M
YoY Change 20.6% 72.13% 244.91%
Depreciation, Depletion And Amortization $82.07K $72.09K $825.4K
YoY Change 40.18% 24.49% 4446.65%
Cash From Operating Activities -$5.217M -$6.795M -$3.328M
YoY Change 701.74% 39.36% 337.69%
INVESTING ACTIVITIES
Capital Expenditures -$260.0K -$125.6K $101.1K
YoY Change -7.05% -87.42% 980.18%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$260.0K -$125.6K -$494.4K
YoY Change -7.05% -101.21% -2.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change -100.0% -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -5.217M -6.795M -3.328M
Cash From Investing Activities -260.0K -125.6K -494.4K
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash -5.477M -6.921M -3.822M
YoY Change -589.15% -214.14% 327.53%
FREE CASH FLOW
Cash From Operating Activities -$5.217M -$6.795M -$3.328M
Capital Expenditures -$260.0K -$125.6K $101.1K
Free Cash Flow -$4.957M -$6.669M -$3.429M
YoY Change 1236.37% 72.0% 345.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20299727
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.84
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20682844
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19847342
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10087809
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19790764
dei Document Transition Report
DocumentTransitionReport
false
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6528886
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20299727
dei Entity Central Index Key
EntityCentralIndexKey
0001844392
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
6304854
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1723760
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2043624
CY2022Q2 us-gaap Goodwill
Goodwill
2382917
dei Entity File Number
EntityFileNumber
001-40904
dei Entity Registrant Name
EntityRegistrantName
MARPAI, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1916231
dei Entity Address Address Line1
EntityAddressAddressLine1
5701 East Hillsborough Ave., Suite 1417
dei Entity Address City Or Town
EntityAddressCityOrTown
Tampa
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33610-5428
dei City Area Code
CityAreaCode
646
dei Local Phone Number
LocalPhoneNumber
303-3483
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
MRAI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20682844
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9084839
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19183044
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
6106210
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
6750599
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26482
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
208762
CY2021Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
14978
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
503823
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
743126
CY2022Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
27284
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
91498
CY2022Q2 us-gaap Assets Current
AssetsCurrent
15748638
CY2021Q4 us-gaap Assets Current
AssetsCurrent
26992007
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
761620
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
889935
CY2022Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
5777050
CY2022Q2 mrai Accrued Fiduciary Obligations Current
AccruedFiduciaryObligationsCurrent
5063552
CY2021Q4 us-gaap Goodwill
Goodwill
2382917
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5121522
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5507693
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
80610
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
80610
CY2022Q2 us-gaap Assets
Assets
31596117
CY2021Q4 us-gaap Assets
Assets
44201640
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
490144
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1125906
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2320550
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2525037
CY2021Q4 mrai Accrued Fiduciary Obligations Current
AccruedFiduciaryObligationsCurrent
5541067
CY2022Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
828425
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1165248
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
829284
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
784493
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
3201
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
3637
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
9535156
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11145388
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
45000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
45000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
944450
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1301828
CY2022Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2001012
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2001012
CY2022Q2 us-gaap Liabilities
Liabilities
12525618
CY2021Q4 us-gaap Liabilities
Liabilities
14493228
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
227791050
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
227791050
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20682844
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
2068
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2030
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
52748587
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
51232092
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33680156
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21525710
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
19070499
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
29708412
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31596117
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44201640
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5556506
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3531512
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11775315
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3531512
CY2022Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
4151560
CY2021Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
2720483
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
8698355
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
2720483
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2319977
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2059608
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5222109
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2861445
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2216788
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1122665
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3775904
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1443785
CY2022Q2 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1189733
CY2021Q2 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
731230
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
2324006
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
731230
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1309157
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
285363
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1902264
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
549374
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
776411
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
402813
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1601809
us-gaap Depreciation And Amortization
DepreciationAndAmortization
420967
CY2022Q2 mrai Facilities Expense
FacilitiesExpense
196341
CY2021Q2 mrai Facilities Expense
FacilitiesExpense
180397
mrai Facilities Expense
FacilitiesExpense
392936
mrai Facilities Expense
FacilitiesExpense
180397
CY2022Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-60471
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-60471
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
12220438
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
7502559
us-gaap Costs And Expenses
CostsAndExpenses
23977854
us-gaap Costs And Expenses
CostsAndExpenses
8907681
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6663932
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3971047
us-gaap Operating Income Loss
OperatingIncomeLoss
-12202539
us-gaap Operating Income Loss
OperatingIncomeLoss
-5376169
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9706
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
47728
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
39291
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
54426
CY2022Q2 us-gaap Interest Expense
InterestExpense
562
CY2021Q2 us-gaap Interest Expense
InterestExpense
92621
us-gaap Interest Expense
InterestExpense
4507
us-gaap Interest Expense
InterestExpense
276061
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
9418
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-6034
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
13309
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-15784
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6664782
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4021974
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12154446
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5613588
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-150000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-150000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-6664782
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-3871974
us-gaap Net Income Loss
NetIncomeLoss
-12154446
us-gaap Net Income Loss
NetIncomeLoss
-5463588
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.84
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19847342
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10087809
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19790764
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6528886
CY2021Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
4.555821
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
24467736
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1244334
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
36
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
23175
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-6664782
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
19070499
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-4806802
CY2021Q2 mrai Stock Issued During Period Value Exchange With Subsidiary
StockIssuedDuringPeriodValueExchangeWithSubsidiary
-14
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
17351935
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
2500
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
475528
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-3871974
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
9151173
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
29708412
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1493322
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
36
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
23175
us-gaap Net Income Loss
NetIncomeLoss
-12154446
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
19070499
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-3496499
mrai Stock Issued During Period Value Exchange With Subsidiary
StockIssuedDuringPeriodValueExchangeWithSubsidiary
-14
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
17351935
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
53333
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
706006
us-gaap Net Income Loss
NetIncomeLoss
-5463588
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
9151173
CY2021Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
4.555821
us-gaap Profit Loss
ProfitLoss
-12154446
us-gaap Profit Loss
ProfitLoss
-5463588
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1601809
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
420967
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-60471
us-gaap Share Based Compensation
ShareBasedCompensation
1743359
us-gaap Share Based Compensation
ShareBasedCompensation
706006
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
23175
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
67816
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
41810
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
26728
us-gaap Paid In Kind Interest
PaidInKindInterest
246230
mrai Convertible Notes Issued In Exchange For Services
ConvertibleNotesIssuedInExchangeForServices
-75000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-150000
mrai Increase Decrease In Accounts Receivable And Unbilled Receivable
IncreaseDecreaseInAccountsReceivableAndUnbilledReceivable
-239305
mrai Increase Decrease In Accounts Receivable And Unbilled Receivable
IncreaseDecreaseInAccountsReceivableAndUnbilledReceivable
13522
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-197258
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
210138
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-64214
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-71443
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-635765
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-582986
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-454487
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
70210
mrai Increase Decrease In Accrued Fiduciary Obligations
IncreaseDecreaseInAccruedFiduciaryObligations
477515
mrai Increase Decrease In Accrued Fiduciary Obligations
IncreaseDecreaseInAccruedFiduciaryObligations
-1125031
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-60539
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-55722
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-337259
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1183378
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10122604
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4875909
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
11384035
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
607700
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
972181
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12290
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26189
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-619990
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10385665
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
500000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
53333
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
553333
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10742594
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6063089
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25933643
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1817932
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15191049
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7881021
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9084839
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2339223
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
6106210
CY2021Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
5541798
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15191049
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7881021
CY2021Q1 mrai Number Of Healthcare Subsidiaries
NumberOfHealthcareSubsidiaries
2
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33680156
CY2022Q2 mrai Working Capital
WorkingCapital
6213482
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
0
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9084839
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingencies at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Such estimates include, but are not limited to, valuation of share-based compensation,valuation of the Company’s common stock prior to the IPO, accounting for warrants, allowance for doubtful accounts, useful lives of internally developed software,fair values of net assets acquired, goodwill, intangible assets and property and equipment, whether an arrangement is or contains a lease, the incremental borrowing rate used for operating leases, income tax accruals, the valuation allowance for deferred income taxes, and contingent liabilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.</p>
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
402496
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
326121
mrai Accounts Receivable Payments Term
AccountsReceivablePaymentsTerm
P30D
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3359974
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6058540
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2558649
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1164116
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1185518
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
7746953
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
7746953
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-7479835
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-7479835
mrai Business Acquisitions Incremental Amortization Expense Related To Intangible And Tangible Assets Acquired
BusinessAcquisitionsIncrementalAmortizationExpenseRelatedToIntangibleAndTangibleAssetsAcquired
303556
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
295583
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
761620
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
889935
us-gaap Depreciation
Depreciation
143205
us-gaap Depreciation
Depreciation
76064
CY2022Q2 us-gaap Depreciation
Depreciation
72094
CY2021Q2 us-gaap Depreciation
Depreciation
57910
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
96770
us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1
36299
CY2022Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
7529900
CY2021Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
7161571
CY2022Q2 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
2322231
CY2021Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1186727
CY2022Q2 mrai Capitalized Computer Software Net Of Accumulated Amortization And In Process
CapitalizedComputerSoftwareNetOfAccumulatedAmortizationAndInProcess
5207669
CY2021Q4 mrai Capitalized Computer Software Net Of Accumulated Amortization And In Process
CapitalizedComputerSoftwareNetOfAccumulatedAmortizationAndInProcess
5974844
CY2022Q2 mrai Capitalized Computer Software In Process
CapitalizedComputerSoftwareInProcess
569381
CY2021Q4 mrai Capitalized Computer Software In Process
CapitalizedComputerSoftwareInProcess
330010
CY2022Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
5777050
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
6304854
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1135504
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
126553
CY2022Q2 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
598575
CY2021Q2 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
126553
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
383571
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
218350
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
166213
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
218350
CY2022Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
4.00
CY2022Q2 us-gaap Noncurrent Assets
NoncurrentAssets
15766869
CY2021Q4 us-gaap Noncurrent Assets
NoncurrentAssets
17129023
CY2022Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
0
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
297000
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
3201
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
3637
CY2022Q2 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
940029
CY2021Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
897288
CY2022Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
776937
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
743038
CY2022Q2 mrai Performance Guarantee Liabilities Current
PerformanceGuaranteeLiabilitiesCurrent
326121
CY2021Q4 mrai Performance Guarantee Liabilities Current
PerformanceGuaranteeLiabilitiesCurrent
418988
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
277463
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
465723
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2320550
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2525037
CY2021Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
4.555821
CY2021Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
24547086
CY2021Q4 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
783257
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
15000
CY2022Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
7500
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0267
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21

Files In Submission

Name View Source Status
0001410578-22-002513-index-headers.html Edgar Link pending
0001410578-22-002513-index.html Edgar Link pending
0001410578-22-002513.txt Edgar Link pending
0001410578-22-002513-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mrai-20220630.xsd Edgar Link pending
mrai-20220630x10q.htm Edgar Link pending
mrai-20220630xex31d1.htm Edgar Link pending
mrai-20220630xex31d2.htm Edgar Link pending
mrai-20220630xex32d1.htm Edgar Link pending
mrai-20220630xex32d2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mrai-20220630_lab.xml Edgar Link unprocessable
mrai-20220630_pre.xml Edgar Link unprocessable
mrai-20220630_def.xml Edgar Link unprocessable
mrai-20220630x10q_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mrai-20220630_cal.xml Edgar Link unprocessable